佐力药业2025年第三季度净利润同比增长8.81%

Core Viewpoint - Zhaoli Pharmaceutical reported a revenue of 680 million yuan for Q3 2025, marking a year-on-year growth of 10.32% and a net profit attributable to shareholders of 136 million yuan, up 8.81% [1] Financial Performance - For the first three quarters of 2025, Zhaoli Pharmaceutical achieved a total revenue of 2.28 billion yuan, reflecting a year-on-year increase of 11.48% [1] - The net profit attributable to shareholders for the same period reached 510 million yuan, representing a year-on-year growth of 21% [1]